Company Overview and News

95
Why Stock Market Will Keep Heading Higher, Despite Inverted Yield Curve

2018-07-21 investorplace
In early February, the stock market was in sell-off mode because inflation and rate hikes were pushing up fixed income yields, which was increasing borrowing costs and pressuring equity valuations.
JD FB SHOP NFLX GOOG NVDA CRM ADBE WB BABA AMZN IQ AAPL BIDU

91
5 Top Stock Trades for Monday — Buy GE and Microsoft?

2018-07-20 investorplace
General Electric (NYSE:GE) and Microsoft (NASDAQ:MSFT) reported earnings and reacted in very different ways. Tesla (NASDAQ:TSLA) could be gearing up for a big move, too. Here are our top stock trades for Monday:
GE F GEC GM.WS.A GM.WS.B GM.WS.C TSLA GNE MSFT GM GM.WSB ADBE

11
Intuit Sells Data Center for Faster Public Cloud Transition

2018-07-20 zacks
Intuit (INTU - Free Report) recently announced that it is selling its largest data center based in Quincy, WA to H5 Data Centers, a privately-owned data center operator in the country. The move resonates with the company’s strategy to shift all services to public cloud instead of investing in owning hosting platforms. By the end of tax season, all its TurboTax online users were served from Amazon (AMZN - Free Report) Web Services, per management.
INTU VRNT KDP ADBE

12
Microsoft (MSFT) Beats Q4 Earnings, Top Line Grows on Azure

2018-07-20 zacks
Microsoft Corporation (MSFT - Free Report) reported fourth-quarter fiscal 2018 earnings of $1.13 per share, beating the Zacks Consensus Estimate by six cents. The figure increased 6.6% on a year-over-year basis. Revenues of $30.09 billion increased 17.5% from the year-ago quarter (up 13% in constant currency or cc). Further, the figure exceeded the Zacks Consensus Estimate of $29.21 billion. Commercial bookings surged 18% (same at cc).
VRNT KDP MSFT ADBE WMT

15
Zacks.com featured highlights include: Mellanox, Microchip, ConocoPhillips and Adobe

2018-07-20 zacks
Chicago, IL – July 20, 2018 - Stocks in this week’s article Mellanox Technologies Ltd. (MLNX - Free Report) , Microchip Technology Inc. (MCHP - Free Report) , ConocoPhillips (COP - Free Report) and Adobe Systems Inc. (ADBE - Free Report) .
COP WLL KDP MLNX MCHP ADBE

10
SAP Q2 Earnings Up Y/Y, Cloud Strength Drives Top-Line Growth

2018-07-19 zacks
SAP SE (SAP - Free Report) reported second-quarter 2018 non-IFRS earnings of €0.98 ($1.17) per share, up 4.3% on a year-over-year basis. However, the bottom line fell short of the Zacks Consensus Estimate of $1.18 per share. On IFRS basis, earnings of €0.60 (71 cents) per share increased 7.1% on a year-over-year basis. Total revenues, on non-IFRS basis, were €6.01 billion ($7.15 billion), up 4% year over year (up 10% at constant currency), better than the Zacks Consensus Estimate of $7.
SAP VRNT SAPGF SAVE DTEGF ADBE DTEGY

15
4 Impressive Liquid Stocks for Marvellous Returns

2018-07-19 zacks
Investors seeking strong returns may allocate their assets in stocks with significant liquidity. Liquidity is an important yardstick that indicates a company’s capability to meet debt obligations by converting assets into cash. A company with a favorable liquidity position has the potential to generate higher returns as liquidity drives growth. However, one should exercise caution before investing in such stocks.
COP MLNX MCHP ADBE

22
RPT-Microsoft's focus on cloud, partnerships paying off

2018-07-19 reuters
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp, a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

50
What's The Best Index ETF For Exposure To Technology Stocks?

2018-07-19 seekingalpha
Investors have several options but the NASDAQ QQQ seems like the best solution in many cases.
IGV HD QQQ BKNG AMZN NDAQ T VZ MSFT FDN ORCL ADBE

21
Microsoft's focus on cloud, partnerships paying off - Channel NewsAsia

2018-07-18 channelnewsasia
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp , a partnership that illustrates how Microsoft's chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

21
Microsoft's focus on cloud, partnerships paying off

2018-07-18 reuters
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp (MSFT.O), a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

12
As Cloud Kings Go, Red Hat Stock Isn’t Looking Very Regal Right Now

2018-07-18 investorplace
Red Hat (NYSE:RHT) has been a player in the digital space for awhile, and Red Hat stock has essentially tripled over the last five years, but it is a whole new environment, now.
SPLK NOW WDAY VMW RHT ADBE

9
Has Adobe Systems (ADBE) Outpaced Other Computer and Technology Stocks This Year?

2018-07-18 zacks
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adobe Systems (ADBE - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
ADBE

9
Business News Roundup, July 18

2018-07-17 sfgate
San Francisco brokerage firm Charles Schwab reported revenue of $2.49 billion and profit of $866 million (60 cents per share), beating analyst estimates.
SCHW.PRBCL TXN ADBE

19
The Story of Salesforce.com (CRM) Stock Sounds Awfully Familiar

2018-07-16 investorplace
From a broad standpoint, the story at Salesforce.com (NYSE:CRM) is pretty simple. The business is hugely attractive. But CRM stock looks overvalued.
SPLK SAP ALGN SQ SHOP MSFT NFLX CRM ORCL ADBE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ADBE / Adobe Systems, Inc. on message board site Silicon Investor.

Adobe (adbe) opinions Adobe, Intel(MMX) and Windows Market
Adobe is it ready to move up?
CUSIP: 00724F101